Español/Spanish English/Inglés

 Neoplasias Hematológicas y Trasplante de Progenitores Hematopoyéticos
 (Grupo IFIMAV Consolidado)

AÑO:  
TOTAL Nº PUBLICACIONES: 6
TOTAL FACTOR IMPACTO: 38,139
Albajar M, Gómez-Casares MT, Llorca J, Mauleon I, Vaqué JP, Acosta JC, Bermúdez A, Donato N, Delgado MD, León J. MYC in chronic myeloid leukemia: induction of aberrant DNA synthesis and association with poor response to imatinib. Mol. Cancer Res. 2011; 9:564-576. F.I.: 4,373

Bretones G, Acosta JC, Caraballo JM, Ferrándiz N, Gómez-Casares MT, Albajar M, Blanco R, Ruiz P, Hung WC, Albero MP, Perez-Roger I, León J. SKP2 oncogene is a direct MYC target gene and MYC down-regulates p27(KIP1) through SKP2 in human leukemia cells. J. Biol. Chem. 2011; 286:9815-9825. F.I.: 5,328

Cayô R, Yañez San Segundo L, Pérez del Molino Bernal IC, García de la Fuente C, Bermúdez Rodríguez MA, Calvo J, Martínez-Martínez L. Bloodstream infection caused by Acinetobacter junii in a patient with acute lymphoblastic leukaemia after allogenic haematopoietic cell transplantation. J. Med. Microbiol. 2011; 60:375-377. F.I.: 2,380

Martinez-Lopez J, Blade J, Mateos MV, Grande C, Alegre A, García-Laraña J, Sureda A, de la Rubia J, Conde E, Martinez R, de Arriba F, Viguria MC, Besalduch J, Cabrera R, Gonzalez-San Miguel JD, Guzman-Zamudio JL, Gomez del Castillo MC, Moraleda JM, García-Ruiz JC, San Miguel J, Lahuerta JJ. Long-term prognostic significance of response in multiple myeloma after stem cell transplantation. Blood 2011; 118:529-534. F.I.: 10,558

Montes-Moreno S, Martinez N, Sanchez-Espiridión B, Díaz Uriarte R, Rodriguez ME, Saez A, Montalbán C, Gomez G, Pisano DG, García JF, Conde E, Gonzalez-Barca E, Lopez A, Mollejo M, Grande C, Martinez MA, Dunphy C, Hsi ED, Rocque GB, Chang J, Go RS, Visco C, Xu-Monette Z, Young KH, Piris MA. miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy. Blood 2011; 118:1034-1040. F.I.: 10,558

Rives S, Estella J, Gómez P, López-Duarte M, de Miguel PG, Verdeguer A, Moreno MJ, Vivanco JL, Couselo JM, Fernández-Delgado R, Maldonado M, Tasso M, López-Ibor B, Lendínez F, López-Almaraz R, Uriz J, Melo M, Fernández-Teijeiro A, Rodríguez I, Badell I. Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005. Br. J. Haematol. 2011; 154:600-611. F.I.: 4,942
© 2012 Fundación Marqués de Valdecilla. Todos los derechos reservados. Nota Legal | Política de Privacidad | Mapa Web | Webmaster